~~<i id='3826D71469'><strike id='3826D71469'><tt id='3826D71469'><pre id='3826D71469'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：explore 2025-09-29 01:07:29 - browse：476

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Biden’s NIH nominee is languishing in Congress

leisure time

Wikipedia

explore

entertainment

leisure time

knowledge

Editor’snote:Arecordingoftheeventisembeddedbelow.Afterafewgo-goyears,theearly-stagebiotechmarkethasc

WSS

What causes an itch? Researchers may have solved the mystery

Parents surprise family after baby discharged from NICU after 170 days

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Spinal cord stimulation reduces pain in amputees, study finds

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Americans' trust in science, scientist continues decline: Report

hotspot

entertainment

leisure time

Activists slam private health insurers over coverage restrictions

Radiology is caught between AI's potential and concern for patients

Bright Health sells Medicare Advantage business to Molina

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Sports medicine is finally prioritizing gender equality

SCOTUS to consider access to abortion pill mifepristone

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

In age of alternative facts, a scholarly course on calling out crap

Radiology is caught between AI's potential and concern for patients

Wikipedia

FDA approves world's first CRISPR

Recent heat wave in the Mediterranean caused by climate change: Study

The aspartame in Diet Coke probably isn’t giving you cancer

FDA approves world's first CRISPR

Why sickle cell disease is getting the first CRISPR treatment

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

explore

entertainment

leisure time

knowledge